Published in J Clin Oncol on December 20, 2005
Racial differences in parents' distrust of medicine and research. Arch Pediatr Adolesc Med (2009) 1.96
Technical desiderata for the integration of genomic data into Electronic Health Records. J Biomed Inform (2011) 1.96
ResearchMatch: a national registry to recruit volunteers for clinical research. Acad Med (2012) 1.85
Patient income level and cancer clinical trial participation. J Clin Oncol (2013) 1.48
Factors associated with enrollment of African Americans into a clinical trial: results from the African American study of kidney disease and hypertension. Contemp Clin Trials (2008) 1.24
Physician-related factors involved in patient decisions to enroll onto cancer clinical trials. J Oncol Pract (2009) 1.14
The impact of insurance on access to cancer clinical trials at a comprehensive cancer center. Clin Cancer Res (2010) 1.09
Pilot intervention outcomes of an educational program for biospecimen research participation. J Cancer Educ (2013) 1.08
Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States. Biol Blood Marrow Transplant (2009) 1.05
African American men's and women's perceptions of clinical trials research: focusing on prostate cancer among a high-risk population in the South. J Health Care Poor Underserved (2013) 1.03
An examination of the influence of patient race and ethnicity on expressed interest in learning about cancer clinical trials. J Cancer Res Clin Oncol (2007) 1.03
Barriers to recruitment of rural patients in cancer clinical trials. J Oncol Pract (2011) 1.01
Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials. J Clin Oncol (2015) 0.98
Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study. Trials (2012) 0.94
State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual. Cancer (2014) 0.93
Recruiting underserved populations to dermatologic research: a systematic review. Int J Dermatol (2011) 0.89
Promoting Factors and Barriers to Participation in Early Phase Clinical Trials: Patients Perspectives. J Community Med Health Educ (2014) 0.88
A pilot study of a culturally targeted video intervention to increase participation of African American patients in cancer clinical trials. Oncologist (2012) 0.87
Statewide cancer clinical trial navigation service. J Oncol Pract (2010) 0.86
Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives. Br J Cancer (2008) 0.85
Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers. Eur J Cancer Care (Engl) (2014) 0.85
Barriers to participation in cancer prevention clinical trials. Acta Oncol (2010) 0.84
Clinical trial awareness: Changes over time and sociodemographic disparities. Clin Trials (2015) 0.84
Unique perception of clinical trials by Korean cancer patients. BMC Cancer (2012) 0.83
Retention of clinical trial participants in a study of nongonococcal urethritis (NGU), a sexually transmitted infection in men. Contemp Clin Trials (2012) 0.82
Psychosocial barriers and facilitators to clinical trial enrollment and adherence for adolescents with cancer. Pediatrics (2014) 0.79
Breast cancer survivors willingness to participate in an acupuncture clinical trial: a qualitative study. Support Care Cancer (2013) 0.79
Participation of older newly-diagnosed cancer patients in an observational prospective pilot study: an example of recruitment and retention. BMC Cancer (2009) 0.79
Attitudes and barriers towards participation in an acupuncture trial among breast cancer patients: a survey study. BMC Complement Altern Med (2014) 0.78
Discussions of cancer clinical trials with the National Cancer Institute's Cancer Information Service. J Health Commun (2011) 0.78
Culturally and linguistically diverse patient participation in glioma research. Neurooncol Pract (2014) 0.78
A Patient Focused Solution for Enrolling Clinical Trials in Rare and Selective Cancer Indications: A Landscape of Haystacks and Needles. Drug Inf J (2012) 0.77
The bottleneck effect in lung cancer clinical trials. J Cancer Educ (2013) 0.75
Rural-urban differences in discussions of cancer treatment clinical trials. Patient Educ Couns (2011) 0.75
Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond. Am Soc Clin Oncol Educ Book (2015) 0.75
Cancer Research Participation Beliefs and Behaviors of a Southern Black Population: A Quantitative Analysis of the Role of Structural Factors in Cancer Research Participation. J Cancer Educ (2015) 0.75
Socioeconomic and clinical factors are key to uncovering disparity in accrual onto therapeutic trials for breast cancer. J Natl Compr Canc Netw (2014) 0.75
Applying a Conceptual Framework to Maximize the Participation of Diverse Populations in Cancer Clinical Trials. Adv Cancer Res (2016) 0.75
A Data Capture Framework for Large-scale Interventional Studies with Survey Workflow Management. AMIA Jt Summits Transl Sci Proc (2017) 0.75
QOL and Survival Comparisons by Race in Oncology Clinical Trials. J Cancer Clin Oncol (2016) 0.75
Access to clinical trials among oncology patients: results of a cross sectional survey. BMC Cancer (2017) 0.75
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging (2002) 6.18
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet (2009) 5.82
Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin (2007) 5.67
Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023. J Clin Oncol (2008) 5.11
Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol (2003) 4.37
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2011) 4.25
Racial and ethnic disparities in the use of health services: bias, preferences, or poor communication? J Gen Intern Med (2003) 4.11
Outcomes of lumbar to sacral nerve rerouting for spina bifida. J Urol (2010) 3.94
The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement (2010) 3.85
Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med (2005) 3.55
Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis (2003) 3.36
Physician communication when prescribing new medications. Arch Intern Med (2006) 3.27
Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement (2010) 3.11
Aurora kinases as anticancer drug targets. Clin Cancer Res (2008) 2.92
A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity. Am J Trop Med Hyg (2004) 2.87
Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy. J Clin Oncol (2008) 2.85
Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials. J Thorac Oncol (2015) 2.80
Natural history of stage I non-small cell lung cancer: implications for early detection. Chest (2007) 2.78
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol (2009) 2.73
Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials. J Clin Oncol (2008) 2.64
Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. J Clin Oncol (2013) 2.59
Contrast-enhanced dedicated breast CT: initial clinical experience. Radiology (2010) 2.58
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426. J Clin Oncol (2009) 2.54
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2013) 2.32
"Building" a history rather than "taking" one: a perspective on information sharing during the medical interview. Arch Intern Med (2003) 2.20
Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. J Clin Oncol (2005) 2.19
Patient engagement programs for recognition and initial treatment of depression in primary care: a randomized trial. JAMA (2013) 2.12
Medical student attitudes toward the doctor-patient relationship. Med Educ (2002) 2.10
Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019. J Clin Oncol (2002) 2.07
Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging (2010) 2.05
The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol (2002) 1.92
Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol (2006) 1.89
Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg (2007) 1.83
English language proficiency and smoking prevalence among California's Asian Americans. Cancer (2005) 1.83
Hepatitis B awareness, knowledge, and screening among Asian Americans. J Cancer Educ (2007) 1.81
Integrating theory into community interventions to reduce liver cancer disparities: The Health Behavior Framework. Prev Med (2009) 1.80
Positron emission tomography and improved survival in patients with lung cancer: the Will Rogers phenomenon revisited. Arch Intern Med (2008) 1.79
Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer. J Natl Cancer Inst (2002) 1.78
High variation between hospitals in vena cava filter use for venous thromboembolism. JAMA Intern Med (2013) 1.72
Asian subgroups and cancer incidence and mortality rates in California. Cancer (2005) 1.71
Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer. J Clin Oncol (2009) 1.70
An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J (2004) 1.68
Phase II study of Aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer, a California Cancer Consortium Trial. Urology (2010) 1.65
Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment. J Rheumatol (2005) 1.64
Pharmacodynamic separation of epidermal growth factor receptor tyrosine kinase inhibitors and chemotherapy in non-small-cell lung cancer. Clin Lung Cancer (2006) 1.61
Salzmann nodular degeneration. Cornea (2010) 1.61
A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study. Clin Cancer Res (2008) 1.60
Size bias of fragile X premutation alleles in late-onset movement disorders. J Med Genet (2006) 1.54
A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas. Clin Cancer Res (2012) 1.53
Epidermal growth factor receptor inhibition in lung cancer: status 2012. J Thorac Oncol (2013) 1.50
Pulmonary function and exercise-associated changes with chronic low-level paraquat exposure. Am J Respir Crit Care Med (2004) 1.48
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer. Cancer Chemother Pharmacol (2009) 1.47
Overcoming barriers to cancer clinical trial accrual: impact of a mass media campaign. Cancer (2008) 1.47
Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study. J Clin Oncol (2007) 1.46
Trends in colorectal cancer testing among Medicare subpopulations. Am J Prev Med (2008) 1.46
A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma. Clin Cancer Res (2008) 1.43
Temporal changes in characteristics of injection-site sarcomas in cats: 392 cases (1990-2006). J Am Vet Med Assoc (2009) 1.43
Venous thromboembolism in ovarian cancer. Gynecol Oncol (2007) 1.42
Examining racial disparities in colorectal cancer care. J Psychosoc Oncol (2009) 1.42
Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group. J Clin Oncol (2005) 1.41
Microvascular abnormalities in sickle cell disease: a computer-assisted intravital microscopy study. Blood (2002) 1.40
Phase I trial of edatrexate in advanced breast and other cancers. Cancer Invest (2002) 1.39
Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group phase II trial (S0327). J Thorac Oncol (2006) 1.39
Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003. J Clin Oncol (2008) 1.38
Disparities in hepatocellular carcinoma survival among Californians of Asian ancestry, 1988 to 2007. Cancer Epidemiol Biomarkers Prev (2010) 1.38
Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. J Clin Oncol (2012) 1.37
Patient preferences for physician characteristics in university-based primary care clinics. Ethn Dis (2003) 1.36
A randomized controlled trial of multiple tailored messages for smoking cessation among callers to the cancer information service. J Health Commun (2005) 1.35
Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care. J Pain Symptom Manage (2004) 1.33
Factors associated with hepatitis B testing among Vietnamese Americans. J Gen Intern Med (2010) 1.33
Generational and gender perspectives on career flexibility: ensuring the faculty workforce of the future. Am J Med (2012) 1.32
A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients. Cytometry B Clin Cytom (2009) 1.31
Schedule-dependent apoptosis in K-ras mutant non-small-cell lung cancer cell lines treated with docetaxel and erlotinib: rationale for pharmacodynamic separation. Clin Lung Cancer (2007) 1.30
Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003. J Clin Oncol (2005) 1.29
Acculturation and its association with health-risk behaviors in a rural Latina population. Ethn Dis (2005) 1.29
Sorafenib in platinum-treated patients with extensive stage small cell lung cancer: a Southwest Oncology Group (SWOG 0435) phase II trial. J Thorac Oncol (2010) 1.29
Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy. Int J Radiat Oncol Biol Phys (2011) 1.27
Physician communication about the cost and acquisition of newly prescribed medications. Am J Manag Care (2006) 1.27
A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study. Anticancer Drugs (2009) 1.26
Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126. J Clin Oncol (2006) 1.25
A novel assay for quantifying the number of plasmids encapsulated by polymer nanoparticles. Small (2011) 1.25
High quit ratio among Asian immigrants in California: implications for population tobacco cessation. Nicotine Tob Res (2007) 1.24
Effects of a problem-solving intervention (COPE) on quality of life for patients with advanced cancer on clinical trials and their caregivers: simultaneous care educational intervention (SCEI): linking palliation and clinical trials. J Palliat Med (2011) 1.24
The AKT inhibitor perifosine in biochemically recurrent prostate cancer: a phase II California/Pittsburgh cancer consortium trial. Clin Genitourin Cancer (2007) 1.23
Community-based advocacy training: applying asset-based community development in resident education. Acad Med (2009) 1.22
Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer. Cancer Res (2008) 1.21
EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer. J Thorac Oncol (2009) 1.21
Incorporating bortezomib into the treatment of lung cancer. Clin Cancer Res (2007) 1.17